SCHEMBL30517176

SCHEMBL30517176

O=C(O)c1cccc(-c2noc(-c3ccc(N4CCCC4)nc3)n2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.55
RAB9A P51151 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
HDAC6 Q9UBN7 3/20 0.50
MAOA P21397 1/20 0.50
BLVRB P30043 1/20 0.50
NR1H4 Q96RI1 1/20 0.47
CPT1A P50416 1/20 0.46
CPT1B Q92523 1/20 0.46
CNR2 P34972 2/20 0.44
RXFP1 Q9HBX9 1/20 0.44
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
GAA P10253 1/20 0.43
HPGD P15428 1/20 0.43
KMT2A Q03164 1/20 0.43
HSD17B10 Q99714 1/20 0.43
SYK P43405 1/20 0.43
CNR1 P21554 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL59273 1.00 NPC1 (0.55) NPC1RAB9AL3MBTL1HDAC6MAOA
SCHEMBL60693 0.99 NPC1 (0.54) NPC1RAB9AL3MBTL1HDAC6MAOA
SCHEMBL60169 0.92 NPC1 (0.53) NPC1RAB9AL3MBTL1HDAC6MAOA
SCHEMBL18950853 0.83 S1PR1 (0.54) NPC1RAB9AHDAC6CNR2RXFP1
SCHEMBL25907906 0.83 S1PR1 (0.53) NPC1RAB9AHDAC6CNR2RXFP1
SCHEMBL60681 0.79 NPC1 (0.69) NPC1RAB9AL3MBTL1HDAC6MAOA
SCHEMBL59247 0.77 RAB9A (0.72) NPC1RAB9AL3MBTL1HDAC6MAOA
SCHEMBL60427 0.77 NPC1 (0.76) NPC1RAB9AL3MBTL1HDAC6MAOA
SCHEMBL17915624 0.76 KMO (0.59) NPC1RAB9AL3MBTL1HDAC6MAOA
SCHEMBL60783 0.75 SMN1; SMN2 (0.67) NPC1RAB9AL3MBTL1HDAC6MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4101846-B1 1,2,4-OXADIAZOLE BENZOIC ACID COMPOUNDS AND THEIR USE FOR NONSENSE SUPPRESSION AND THE TREATMENT OF DISEASE PTC THERAPEUTICS INC (US) 2023-08-02 EP disclosed